Shang Hai Zheng Quan Bao
Search documents
人保睿逸智选混合型证券投资基金基金份额发售公告
Shang Hai Zheng Quan Bao· 2026-02-12 18:34
基金管理人:中国人保资产管理有限公司 基金托管人:苏州银行股份有限公司 二O二六年二月 【重要提示】 1、人保睿逸智选混合型证券投资基金(以下简称"本基金")于2025年12月17日经中国证监会证监许可 [2025]2804号文准予募集注册。中国证监会对本基金的注册并不代表中国证监会对本基金的风险和收益 做出实质性判断、推荐或者保证。 2、本基金是契约型开放式、混合型证券投资基金。 3、本基金的基金管理人和登记机构为中国人保资产管理有限公司(以下简称"本公司"),基金托管人为 苏州银行股份有限公司(以下简称"苏州银行")。 4、本基金的发售对象为符合法律法规规定的可投资于证券投资基金的个人投资者、机构投资者、合格 境外机构投资者、人民币合格境外机构投资者以及法律法规或中国证监会允许购买证券投资基金的其他 投资人。 5、本基金基金份额将于2026年3月2日至2026年3月16日通过销售机构公开发售。具体办理业务时间见各 销售机构的相关业务公告或拨打客户服务电话咨询。本基金的销售机构包括本公司直销机构及各代销平 台。 6、投资者欲购买本基金,需开立登记机构提供的基金账户。基金募集期内本公司、本公司直销柜台及 网站 ...
上海复旦微电子集团股份有限公司关于召开2026年第一次临时股东会、2026年第一次A股类别股东会及2026年第一次H股类别股东会通知

Shang Hai Zheng Quan Bao· 2026-02-12 18:04
A股证券代码:688385 证券简称:复旦微电 公告编号:2026-005 港股证券代码:01385 证券简称:上海复旦 上海复旦微电子集团股份有限公司 关于召开2026年第一次临时股东会、2026年第一次A股类别股东会及2026年第一次H股类别股东会通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的 真实性、准确性和完整性依法承担法律责任。 至2026年3月16日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股东会召开当日的交易时间 段,即9:15-9:25,9:30-11:30,13:00-15:00;通过互联网投票平台的投票时间为股东会召开当日的9:15- 15:00。 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 重要内容提示: 2026年第一次临时股东会、2026年第一次A股类别股东会及2026年第一次H股类别股东会 召开日期时间:2026年3月16日 13点30分 召开地点:上海国泰路127号复旦国家大学科技园4号楼会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统:上海证券交易所股东会网络投票系统 ...
浙江棒杰控股集团股份有限公司第六届董事会第二十四次会议决议公告
Shang Hai Zheng Quan Bao· 2026-02-12 18:02
登录新浪财经APP 搜索【信披】查看更多考评等级 浙江棒杰控股集团股份有限公司 第六届董事会第二十四次会议 决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 浙江棒杰控股集团股份有限公司(以下简称"公司") 第六届董事会第二十四次会议于2026年2月12日在公 司会议室以现场表决与通讯表决相结合的方式召开。全体董事一致同意豁免本次会议通知期限,会议通 知以短信形式送达。会议应出席董事9名,实际出席董事9名。本次会议由董事长曹远刚先生召集并主 持,会议的召集、召开符合《公司法》、《公司章程》的有关规定,表决所形成的决议合法、有效。 二、董事会会议审议情况 (一)审议通过了《关于与扬州经济技术开发区管理委员会签订〈调解协议〉的议案》,并提请股东会 审议 证券代码:002634 证券简称:棒杰股份 公告编号:2026-021 表决结果:9票同意、0票反对、0票弃权。 本议案已经公司董事会战略委员会及审计委员会审议通过。 《关于拟签署〈调解协议〉暨重大诉讼进展的公告》(公告编号:2026-022)具体内容登载于2026年2 月13日《证 ...
中国国际金融股份有限公司关于间接持股全资子公司发行中期票据并由直接持股全资子公司提供担保的公告
Shang Hai Zheng Quan Bao· 2026-02-12 18:00
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 证券代码:601995 证券简称:中金公司 公告编号:临2026-009 ■ 1 本公告所述"担保金额""担保余额"及"担保总额"在计算时仅包含固定利率票据的本金及利息以及浮动 利率票据的本金;浮动利率票据利息需根据实际情况确定。本公告所载金额涉及汇率的,均按照2026年 1月31日人民币兑美元、人民币兑港币汇率折算。 ● 累计担保情况 ■ 中国国际金融(国际)有限公司(曾用名"中国国际金融(香港)有限公司",以下简称"中金国际")为 中国国际金融股份有限公司(以下简称"公司"或"中金公司")直接持股的全资子公司。中金国际直接持 有CICC Hong Kong Finance 2016 MTN Limited(以下简称"发行人"或"被担保人")100%的股权。发行人 于2016年5月5日设立了境外中期票据计划(以下简称"中期票据计划")。截至本公告披露日,该中期票 据计划下可发行的票据本金最高额为100亿美元。中金国际作为发行人的唯一股东,为发行人在中期票 据计划下的发行提供担保。 中国国际金融股份有限公司 关于间接持股全资子公司发行中 ...
天津泰达资源循环集团股份有限公司关于为三级子公司曹妃甸润电环保提供担保的公告
Shang Hai Zheng Quan Bao· 2026-02-12 18:00
Summary of Key Points Core Viewpoint - The company, Tianjin TEDA Resource Recycling Group Co., Ltd., has announced that it will provide guarantees for its subsidiary, Caofeidian Run Electric Environmental Protection Co., Ltd., to secure financing from financial institutions for operational needs [3][13]. Group 1: Guarantee Overview - Caofeidian Run Electric Environmental Protection Co., Ltd. has applied for financing of 30 million yuan from TEDA Leasing Co., Ltd. for a term of 36 months, with the company providing a joint liability guarantee [3]. - The company will also provide a guarantee of 7 million yuan for financing from China Construction Bank for a term of 12 months, with its second-level subsidiary, Tianjin Run Tai Environmental Protection Co., Ltd., providing the guarantee [3]. Group 2: Guarantee Amount and Approval - The total guarantee amount approved for Caofeidian Run Electric Environmental Protection Co., Ltd. for 2026 is 36 million yuan, with a remaining balance of 10.06 million yuan after this guarantee [4]. - The total guarantee amount for Tianjin Run Tai Environmental Protection Co., Ltd. is 35 million yuan, with a remaining balance of 6.99 million yuan after this guarantee [4]. Group 3: Financial Data and Risk Assessment - The company has a total guarantee balance of 11.638 billion yuan, which accounts for 202.89% of the latest audited net assets [2][13]. - The board of directors believes that the risks associated with the guarantees are controllable, given the asset quality of the guaranteed subsidiary [13].
甘肃莫高实业发展股份有限公司关于2025年度审计机构变更项目质量控制复核人的公告
Shang Hai Zheng Quan Bao· 2026-02-12 18:00
证券代码:600543 证券简称:莫高股份 公告编号:临2026-05 一、本次质量控制复核人变更基本情况 大信所为公司2025年度审计机构,原指派李洪先生作为质量控制复核人,为公司提供审计服务。因大信 所内部工作调整,现委派付勇先生担任公司2025年年报审计项目质量控制复核人。 二、变更后的质量控制复核人基本情况 1. 基本信息:付勇先生,2009年取得注册会计师执业资格,2015年开始从事上市公司审计工作,2014年 12月开始在大信所执业。承办过重庆港、远达环保等证券业务的审计工作。近三年复核过的上市公司包 括中设咨询。未在其他单位兼职。 甘肃莫高实业发展股份有限公司 关于2025年度审计机构变更项目质量控制复核人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 甘肃莫高实业发展股份有限公司(以下简称"公司")于2025年4月25日召开第十一届董事会第二次会 议,审议通过了《关于续聘会计师事务所的议案》,同意续聘大信会计师事务所(特殊普通合伙)(以 下简称"大信所")为公司2025年度财务报告和内部控制的审计机构( ...
菲林格尔家居科技股份有限公司关于回复上海证券交易所对公司2025年度业绩预告相关事项的监管工作函的公告
Shang Hai Zheng Quan Bao· 2026-02-12 17:57
Core Viewpoint - The company has responded to the Shanghai Stock Exchange's inquiry regarding its 2025 performance forecast, emphasizing compliance with revenue recognition policies and providing detailed information on its business segments and customer transactions [1][2]. Group 1: Revenue Recognition - The company reported that its revenue from flooring products for 2024 and 2025 was 258.53 million RMB and 264.68 million RMB, accounting for 79.59% and 75.58% of total revenue respectively, with a slight increase in sales but a decrease in percentage due to higher sales from its subsidiary [2][4]. - The revenue recognition policy has remained unchanged during the reporting period, adhering to the relevant accounting standards, and there are no indications of premature or deferred revenue recognition to avoid delisting risk [3][4]. Group 2: Major Customers - The company provided a list of its top ten customers across its business segments, including flooring, cabinetry, and wood finishes, detailing customer names, relationships, contract dates, and payment statuses [4][6]. - Notably, some customers are identified as related parties due to their connections with the company's former actual controller, which may influence the company's interests [4][5]. Group 3: Engineering Projects - The company categorized its engineering projects into those with and without installation agreements, specifying that revenue recognition for projects with agreements is based on obtaining acceptance documents [6][7]. - The company confirmed that there are no instances of premature or deferred revenue recognition in its engineering projects, with all transactions documented and compliant with accounting standards [11]. Group 4: Related Party Transactions - The company disclosed details of transactions with its former actual controller and related entities, ensuring that the pricing and revenue recognition policies for these transactions are consistent with non-related business transactions [9][11]. - The company is undergoing an audit to verify the fairness and commercial substance of these related party transactions, with no anomalies reported thus far [11][12]. Group 5: Revenue Deductions - The company reported a total of 5.1994 million RMB in revenue deductions, primarily from non-core business activities, confirming that all deductions were accurately accounted for and compliant with regulatory guidelines [13][14]. - The auditing process has not revealed any inaccuracies or omissions in the reported revenue deductions, with further verification planned [14].
湖南华纳大药厂股份有限公司自愿披露关于公司参与国家组织集采药品协议期满品种接续采购拟中选的公告
Shang Hai Zheng Quan Bao· 2026-02-12 17:57
Core Viewpoint - Hunan Warner Pharmaceutical Co., Ltd. has participated in the national organized procurement of drugs and has announced that several of its products are proposed to be selected for the continuation of procurement after the expiration of the previous agreement [1][3]. Group 1: Proposed Selected Products - The company has a total of 12 products proposed for selection in this procurement process [3]. - The procurement cycle for the selected products will last until December 31, 2028, starting from the actual execution date of the selection results [2]. Group 2: Financial Impact - The projected sales revenue from the selected products is estimated to be 176.18 million yuan for 2024, accounting for 12.47% of the company's total revenue for that year [3]. - For the period from January to September 2025, the expected sales revenue is 192.05 million yuan, representing 17.69% of the company's revenue for that period [3]. - The selected products are expected to enhance the company's market share and brand influence as medical institutions will prioritize these products during the procurement cycle [3].
广东九联科技股份有限公司关于2025年度以简易程序向特定对象发行股票预案修订说明的公告
Shang Hai Zheng Quan Bao· 2026-02-12 17:47
Group 1 - The company held its sixth board meeting on October 10, 2025, where it approved the proposal for a simplified procedure to issue shares to specific targets for the year 2025 [2][10] - A revised proposal for the share issuance was approved in a subsequent board meeting on February 12, 2026, and the related documents were disclosed on the Shanghai Stock Exchange website [2][10] - The issuance plan does not imply any substantive judgment or approval from regulatory bodies, and its effectiveness is subject to approval from the Shanghai Stock Exchange and registration by the China Securities Regulatory Commission [2][10] Group 2 - The company announced a change in its sponsor institution and representatives, appointing Guolian Minsheng Securities as the new sponsor for the 2025 share issuance [4][6] - The previous sponsor, Shenwan Hongyuan, will transfer its ongoing supervisory responsibilities to Guolian Minsheng due to the new appointment [6][7] - The company expressed gratitude to Shenwan Hongyuan and its representatives for their work during the supervision period [7] Group 3 - The company will hold its first extraordinary general meeting of 2026 on March 3, 2026, with both on-site and online voting options available for shareholders [11][14] - The meeting will discuss several proposals, including the revised plan for the share issuance and measures to mitigate the dilution of immediate returns for shareholders [14][45] - Shareholders must register to attend the meeting, and specific voting procedures are outlined for different types of shareholders [19][20]
“国产AI芯片六小龙”竞速 上海助推“中国算力”破局
Shang Hai Zheng Quan Bao· 2026-02-12 17:42
Core Viewpoint - The article highlights the rapid development and competitive landscape of domestic AI chip companies in China, particularly focusing on the six emerging players in Shanghai, which are poised for significant growth and innovation in the AI sector [2][10]. Group 1: Company Developments - Hanbo Semiconductor has completed its guidance for an IPO on the Sci-Tech Innovation Board and is progressing steadily towards its public offering [2]. - Suiruan Technology's IPO application has been accepted, indicating a growing interest in AI chip companies [2]. - The six domestic AI chip companies, including Hanbo Semiconductor, are collectively referred to as the "Six Little Dragons," with a strong emphasis on technological advancements and product development [2][4]. Group 2: Market Position and Strategy - The "Six Little Dragons" are primarily cloud-based AI chip manufacturers, with five of them focusing on GPGPU architecture to compete with global giants like NVIDIA and AMD [2][4]. - Hanbo Semiconductor specializes in cloud AI inference and has achieved commercial success in both general AI and rendering applications, positioning itself as a leader in the domestic market [3][4]. - The companies are actively updating their technology and product lines, with significant launches such as the new GPU brand by Muxi Co., which aims to enhance scientific research capabilities [3][4]. Group 3: Financial Performance and Projections - Muxi Co. anticipates a revenue of 1.6 billion to 1.7 billion yuan in 2025, reflecting a year-on-year growth of 115.32% to 128.78% [9]. - Moer Thread expects a revenue of 1.45 billion to 1.52 billion yuan in 2025, with a projected year-on-year increase of 230.70% to 246.67% [9]. - The domestic general GPU market share is expected to rise from 8.3% in 2022 to over 50% by 2029, indicating a structural transformation in the market [10]. Group 4: Government and Investment Support - Shanghai has been proactive in nurturing the AI chip industry through financial support and favorable policies, positioning itself as a leader in the integrated circuit sector [5][7]. - The Shanghai Sci-Tech Innovation Fund has been involved in early-stage investments in companies like Muxi, demonstrating strong government backing for local tech firms [6]. - Hanbo Semiconductor has received significant investments from local state-owned enterprises, benefiting from various policy supports aimed at fostering high-quality development in the tech sector [7].